TY  - CHAP
M1  - Book, Section
TI  - Antifungals
A1  - Ghannoum, Mahmoud
A1  - Salem, Iman
A1  - Christensen, Luisa
A2  - Kang, Sewon
A2  - Amagai, Masayuki
A2  - Bruckner, Anna L.
A2  - Enk, Alexander H.
A2  - Margolis, David J.
A2  - McMichael, Amy J.
A2  - Orringer, Jeffrey S.
PY  - 2019
T2  - Fitzpatrick's Dermatology, 9e
AB  - AT-A-GLANCETopical  agents  should  be  used  for  superficial  fungal  infections  of  limited  extent.Topical  agents  have  the  advantage  of  low  cost,  nonprescription  availability,  ease  of  use,  and  high  patient  compliance.Topical  antifungals  include  imidazoles,  allylamines,  benzylamines,  polyenes,  and  ciclopirox.A  number  of  new  carrier  vehicles  have  been  investigated  to  improve  the  bioavaliabilty  of  topical  antifungals.Systemic  agents  should  be  used  to  treat  onychomycosis  and  tinea  capitis,  or  when  superficial  fungal  infection  affects  a  large  surface  area.Attention  should  be  paid  to  drug–drug  interactions  when  prescribing  systemic  antifungals.Combination  therapy  with  topical  and  systemic  drugs  presents  several  advantages.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/18
UR  - dermatology.mhmedical.com/content.aspx?aid=1161343881
ER  -